"Inappropriate marketing" tarnishes pharma's rep, survey finds

01/14/2013 | Pharmalot.com

The reputation of the pharmaceutical industry has tumbled, with 42% of 500 patient groups in 2011 giving the industry an "excellent" or "good" rating and just 34% of 600 patient groups doing so in 2012, per a Patient View survey. Further, half of those surveyed ranked the industry "poor" on fair pricing, and 40% said the reputation of the industry had declined. Patients offered myriad complaints, including "inappropriate marketing, a designation that included off-label marketing," writes Ed Silverman.

View Full Article in:

Pharmalot.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Actuary
Meridian Health Plan
Detroit, MI
Vice President of Finance
Urban Health Plan, Inc.
Bronx, NY
Director of Payor/Provider Contracting
U.S. Medical Management
Tryo, MI